Abstract
The first published guidance from the National Institute for Clinical Excellence (NICE) started with the words “the practice of prophylactic removal of pathology-free impacted third molars should be discontinued in the NHS” [1]. Since then, NICE has produced almost 300 more technological appraisals of medical devices, tests, surgical procedures and, mainly, drugs. Maybe it is time to assess whether health technology assessment (HTA) has reached its coming of age or is merely an impacted molar in the decision-making process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
NICE. National Institute for Clinical Excellence. Guidance on the extraction of wisdom teeth. Technology Appraisal Guidance No. 1. March 2000. Available at: http://www.nice.org.uk/nicemedia/live/11385/31993/31993.pdf.
Blomqvist A, Busby C, Husereau D. Capturing value from health technologies in lean times. C.D. HOWE Institute. Commentary No. 396. Toronto. 2013.
Banta D. What is technology assessment? Int J Technol Assess Health Care. 2009;25 Suppl 1:7-9. doi: 10.1017/S0266462309090333.
O’Donnell JC, Pham SV, Pashos CL, Miller DW, Smith MD. Health technology assessment in evidence-based health care reimbursement decisions around the world: an overview. Value Health. 2009;12(Suppl. 2):S1-5.
Towse A, Buxton M. Three challenges to achieving better analysis for better decisions: generalisability, complexity and thresholds. OHE briefing no 42, October 2006.
Healy P. Pugatch MP. Theory versus Practice: discussing the governance of health technology assessment systems, Stockholm Network. London 2009.
Eddy D. Health technology assessment and evidence-based medicine: what are we talking about? Value Health. 2009;12(Suppl. 2):S6-7.
Sorenson C, Drummond M, Kristensen B, Busse R. How can the impact of health technology assessments be enhanced? European Observatory on Health Systems and Policies, World Health Organization 2008.
Goodman C. HTA 101. Introduction to Health Technology Assessment. Bethesda, MD: National Library of Medicine, National Information Center on Health Services Research and Health Care Technology, 2004. Available from: http://www.nlm.nih.gov/nichsr/hta101/hta101.pdf.
Schwarzer R, Siebert U. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden. Int J Technol Assess Health Care. 2009; 25(3):305-14.
Parada A, Gutierrez-Ibarluzea I, grupo AUnETS. Evaluacion del impacto bibliografico de las agencias y unidades espanolas de evaluacion de tecnologias sanitarias. MInisterio de Sanidad, Servicios Sociales e Igualdad. Madrid 2014.
Wright D, Milne R, Price A, Tose N. Assessing the international use of health technology assessments: exploring the merits of different methods when applied to the National Institute of Health Research Health Technology Assessment (NIHR HTA) programme. Int J Technol Assess Health Care. 2013;29(2):192-7.
Gerhardus A, Dorendorf E, Rottingen JA, Sarria Santamera A. What are the effects of HTA reports on the health system? Ch. 6. In: Velasco Garrido M, Kristensen FB, Palmhoj Nielsen C, Busse R (eds). Health technology assessment and health policymaking in Europe. Current status, challenges and potential. Copenhagen (Denmark): World Health Organization, on behalf of the European Observatory on Health Systems and Policies; 2008. Available in: www.euro.who.int/Document/E91922.pdf.
HTA Glossary. HTAi (Health Technology Assessment International). Oct 8, 2013. (http://htaglossary.net/health+technology+assessment+%28HTA%29).
WHO. Health technology assessment. http://www.who.int/medical_devices/assessment/en/.
EUnetHTA (European network for Health Technology Assessment) http://www.eunethta.eu/about-us/faq.
Banta HD, Luce BR. Health care technology and its assessment: an international perspective. New York, NY: Oxford University Press; 1993.
Coates & Jarratt, Inc. Course workbook: technology assessment. Anticipating the consequences of technological choices. Washington, DC. 1992.
Clement FM1, Harris A, Li JJ, Yong K, Lee KM, Manns BJ. Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. JAMA. 2009 Oct 7;302(13):1437-43.
Dakin H, Devlin N, Feng Y, Rice N, O’Neill P, Parkin D. The influence of cost-effectiveness and other factors on NICE decisions. HERC research paper 05/14. Oxford: Health Economics Research Centre. 2014.
Schaffer SK, Sussex J, Devlin N, Walker A. Searching for Cost-effectiveness Thresholds in NHS Scotland. Office of Health Economics. Research paper 13/07. London 2013.
Gerhardus A, Dintsios CM. The impact of HTA reports on health policy: a systematic review. GMS Health Technol Assess. 2005 Nov 2;1:Doc02. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011311/pdf/HTA-01-02.pdf.
Schaffer SK, Sussex J, Hughes D, Devlin N. Opportunity Costs of Implementing NICE Decisions in NHS Wales. Office of Health Economics. Research paper 14/02. London 2014.
Husereau D, Cameron CG. Value-based pricing of pharmaceuticals in Canada: Opportunities to expand the role of health technology assessment? Canadian Health Services Research Foundation. Paper 5. Ottawa 2011 (http://www.cfhi-fcass.ca/sf-docs/default-source/commissioned-researchreports/Husereau-Dec2011-EN.pdf?sfvrsn=0).
Birch S, Gafni A. Economists’ dream or nightmare? Maximizing health gains from available resources using the NICE guidelines. Health Economics Policy and Law. 2007;2:193-202.
Drummond M. Twenty years of using economic evaluations for reimbursement decisions. What have we achieved? CHE Research paper 75, University of York, 2012.
Gafni A, Birch S. Inclusion of drugs in provincial drug benefit programs: should “reasonable decisions” lead to uncontrolled growth in expenditures? CMAJ. 2003;168(7):849-51.
The Economist Intelligence Unit Healthcare. Value-based healthcare. The implications for pharma strategy, London, 2014.
Peckham M. Scientific basis of health services. London: BMJ Pub. Group; 1996.
Lavis JN, Wilson MG, Oxman AD, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health policymaking (STP) 4: using research evidence to clarify a problem. Health Res Policy Syst. 2009;7 Suppl 1:S4.
Lehoux P, Denis J-L, Tailliez S, Hivon M. Dissemination of health technology assessments: identifying the visions guiding an evolving policy innovation in Canada. J Health Polit Policy Law. 2005;30(4):603-41.
McCloskey D. Knowledge and persuasion in economics. Cambridge University Press, 1994.
Culyer AJ. Social values in health and social care. London: Commission on the Future of Health and Social Care in England – The King’s Fund. 2014. Available: http://www.kingsfund.org.uk/sites/files/kf/media/commission-background-paper-social-valueshealth-social-care.pdf.
Innvaer S, Vist G, Trommald M, Oxman A. Health policy-makers’ perceptions of their use of evidence: a systematic review. J Health Serv Res Policy. 2002;7(4):239-44.
Mitton C, Adair CE, McKenzie E, Patten SB, Waye Perry B. Knowledge transfer and exchange: review and synthesis of the literature. Milbank Q. 2007;85(4):729-68.
Stafinski T, Menon D, Marshall D, Caulfield T. Societal values in the allocation of healthcare resources: is it all about the health gain? Patient. 2011;4(4):207-25.
Rawlins MD. Evidence, values, and decision making. Int J Technol Assess Health Care. 2014; 30(2):233-8.
Drummond M, Sorenson C. Nasty or nice? A perspective on the use of health technology assessment in the United Kingdom. Value Health. 2009;12 Suppl 2:S8-13.
Kranzberg’s M. Technology and history: “Kranzberg’s Laws” Bulletin of Science, Technology Society. 1995;15:5-13.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Meneu, R. (2015). The Wisdom Tooth of Health Technology Assessment. In: del Llano-Señarís, J., Campillo-Artero, C. (eds) Health Technology Assessment and Health Policy Today: A Multifaceted View of their Unstable Crossroads. Adis, Cham. https://doi.org/10.1007/978-3-319-15004-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-15004-8_3
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-15003-1
Online ISBN: 978-3-319-15004-8
eBook Packages: Business and EconomicsEconomics and Finance (R0)